The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling
Open Access
- 12 May 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 27 (39), 5182-5194
- https://doi.org/10.1038/onc.2008.157
Abstract
Chemoresistance represents a major problem in the treatment of many malignancies. Overcoming this obstacle will require improved understanding of the mechanisms responsible for this phenomenon. The progenitor cell marker NG2/melanoma proteoglycan (MPG) is aberrantly expressed by various tumors, but its role in cell death signaling and its potential as a therapeutic target are largely unexplored. We have assessed cytotoxic drug-induced cell death in glioblastoma spheroids from 15 patients, as well as in five cancer cell lines that differ with respect to NG2/MPG expression. The tumors were treated with doxorubicin, etoposide, carboplatin, temodal, cisplatin and tumor necrosis factor (TNF)α. High NG2/MPG expression correlated with multidrug resistance mediated by increased activation of α3β1 integrin/PI3K signaling and their downstream targets, promoting cell survival. NG2/MPG knockdown with shRNAs incorporated into lentiviral vectors attenuated β1 integrin signaling revealing potent antitumor effects and further sensitized neoplastic cells to cytotoxic treatment in vitro and in vivo. Thus, as a novel regulator of the antiapoptotic response, NG2/MPG may represent an effective therapeutic target in several cancer subtypes.Keywords
This publication has 54 references indexed in Scilit:
- NG2, a novel proapoptotic receptor, opposes integrin α4 to mediate anoikis through PKCα-dependent suppression of FAK phosphorylationCell Death & Differentiation, 2008
- Differential phosphorylation of NG2 proteoglycan by ERK and PKCα helps balance cell proliferation and migrationThe Journal of cell biology, 2007
- Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanismsThe Journal of cell biology, 2004
- Regulation of tumor angiogenesis by integrin-linked kinase (ILK)Cancer Cell, 2004
- Binding of the NG2 Proteoglycan to Kringle Domains Modulates the Functional Properties of Angiostatin and Plasmin(ogen)Journal of Biological Chemistry, 2000
- NG2 expression in MLL rearranged acute myeloid leukaemia is restricted to monoblastic casesBritish Journal of Haematology, 1999
- Expression of the NG2 proteoglycan enhances the growth and metastatic properties of melanoma cellsJournal of Cellular Physiology, 1998
- Integrins and anoikisCurrent Opinion in Cell Biology, 1997
- A Central Segment of the NG2 Proteoglycan Is Critical for the Ability of Glioma Cells to Bind and Migrate toward Type VI CollagenExperimental Cell Research, 1997
- Regulation of the VLA integrin-ligand interactions through the beta 1 subunit.The Journal of cell biology, 1992